BIOMAT Database Logo BIOMAT Database Logo

Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients. 2011

Akiho Sawai, and Yasuhiko Ito, and Masashi Mizuno, and Yasuhiro Suzuki, and Susumu Toda, and Isao Ito, and Ryohei Hattori, and Yoshihisa Matsukawa, and Momokazu Gotoh, and Yoshifumi Takei, and Yukio Yuzawa, and Seiichi Matsuo
Department of Nephrology and Renal Replacement Therapy, Nagoya University Graduate School of Medicine, Nagoya, Japan.

BACKGROUND High baseline peritoneal solute transport rate is reportedly associated with reduced patient and technique survival in continuous peritoneal dialysis (PD) patients. However, the determinants of baseline peritoneal solute transport rate remain uncertain. The aim of this study was to investigate the relationship between peritoneal local inflammation, angiogenesis and systemic inflammation and baseline peritoneal permeability. METHODS Peritoneal biopsy specimens from 42 pre-dialysis uraemic patients and 11 control individuals were investigated. Immunohistochemistry for CD68-positive macrophages, chymase- and tryptase-positive mast cells, interleukin-6 (IL-6)-positive cells, CD3-positive T cells, CD20-positive B cells, neutrophils and CD31- and pathologische anatomie Leiden-endothelium (PAL-E)-positive blood vessels in the peritoneum was performed. Baseline dialysate-to-plasma ratio for creatinine (D/P Cr) was determined within 6 months of PD induction. Clinical and laboratory parameters were measured at the time of peritoneal biopsy. Factors associated with peritoneal permeability were assessed by multiple linear regression analysis. RESULTS Pre-dialysis uraemic peritoneum showed infiltration by CD68-positive macrophages, and mast cells, as compared with controls. Baseline D/P Cr was correlated with density of CD68-positive macrophages (P < 0.001), IL-6-positive cells (P < 0.001), CD31-positive (P < 0.05) and PAL-E-positive blood vessels (P < 0.05) and serum albumin (P < 0.05). However, baseline peritoneal permeability was not correlated with infiltration by mast cells, B cells, T cells, neutrophils, serum C-reactive protein or other clinical factors. On multiple linear regression analysis, the number of CD68-positive macrophages in peritoneum was an independent predictor for baseline peritoneal permeability (P = 0.009). CONCLUSIONS Peritoneal macrophage infiltration is predominant in uraemic patients and is an important factor in predicting baseline peritoneal permeability.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females

Related Publications

Akiho Sawai, and Yasuhiko Ito, and Masashi Mizuno, and Yasuhiro Suzuki, and Susumu Toda, and Isao Ito, and Ryohei Hattori, and Yoshihisa Matsukawa, and Momokazu Gotoh, and Yoshifumi Takei, and Yukio Yuzawa, and Seiichi Matsuo
Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.
July 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Akiho Sawai, and Yasuhiko Ito, and Masashi Mizuno, and Yasuhiro Suzuki, and Susumu Toda, and Isao Ito, and Ryohei Hattori, and Yoshihisa Matsukawa, and Momokazu Gotoh, and Yoshifumi Takei, and Yukio Yuzawa, and Seiichi Matsuo
Effects of interleukin-6 T15A single nucleotide polymorphism on baseline peritoneal solute transport rate in incident peritoneal dialysis patients.
January 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Akiho Sawai, and Yasuhiko Ito, and Masashi Mizuno, and Yasuhiro Suzuki, and Susumu Toda, and Isao Ito, and Ryohei Hattori, and Yoshihisa Matsukawa, and Momokazu Gotoh, and Yoshifumi Takei, and Yukio Yuzawa, and Seiichi Matsuo
Peritoneal small solute transport rate is related to the malnutrition inflammation score in peritoneal dialysis patients.
January 2007, Nephron. Clinical practice,
Akiho Sawai, and Yasuhiko Ito, and Masashi Mizuno, and Yasuhiro Suzuki, and Susumu Toda, and Isao Ito, and Ryohei Hattori, and Yoshihisa Matsukawa, and Momokazu Gotoh, and Yoshifumi Takei, and Yukio Yuzawa, and Seiichi Matsuo
Acute systemic inflammation is associated with an increase in peritoneal solute transport rate in chronic peritoneal dialysis patients.
January 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Akiho Sawai, and Yasuhiko Ito, and Masashi Mizuno, and Yasuhiro Suzuki, and Susumu Toda, and Isao Ito, and Ryohei Hattori, and Yoshihisa Matsukawa, and Momokazu Gotoh, and Yoshifumi Takei, and Yukio Yuzawa, and Seiichi Matsuo
Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
March 2010, American journal of physiology. Renal physiology,
Akiho Sawai, and Yasuhiko Ito, and Masashi Mizuno, and Yasuhiro Suzuki, and Susumu Toda, and Isao Ito, and Ryohei Hattori, and Yoshihisa Matsukawa, and Momokazu Gotoh, and Yoshifumi Takei, and Yukio Yuzawa, and Seiichi Matsuo
Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
May 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Akiho Sawai, and Yasuhiko Ito, and Masashi Mizuno, and Yasuhiro Suzuki, and Susumu Toda, and Isao Ito, and Ryohei Hattori, and Yoshihisa Matsukawa, and Momokazu Gotoh, and Yoshifumi Takei, and Yukio Yuzawa, and Seiichi Matsuo
Cytokine profiles in peritoneal dialysis effluent predicts the peritoneal solute transport rate in continuous ambulatory peritoneal dialysis patients.
January 2015, International journal of clinical and experimental medicine,
Akiho Sawai, and Yasuhiko Ito, and Masashi Mizuno, and Yasuhiro Suzuki, and Susumu Toda, and Isao Ito, and Ryohei Hattori, and Yoshihisa Matsukawa, and Momokazu Gotoh, and Yoshifumi Takei, and Yukio Yuzawa, and Seiichi Matsuo
Increased peritoneal solute transport in diabetic peritoneal dialysis patients.
January 1995, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
Akiho Sawai, and Yasuhiko Ito, and Masashi Mizuno, and Yasuhiro Suzuki, and Susumu Toda, and Isao Ito, and Ryohei Hattori, and Yoshihisa Matsukawa, and Momokazu Gotoh, and Yoshifumi Takei, and Yukio Yuzawa, and Seiichi Matsuo
Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients.
January 2014, BMC nephrology,
Akiho Sawai, and Yasuhiko Ito, and Masashi Mizuno, and Yasuhiro Suzuki, and Susumu Toda, and Isao Ito, and Ryohei Hattori, and Yoshihisa Matsukawa, and Momokazu Gotoh, and Yoshifumi Takei, and Yukio Yuzawa, and Seiichi Matsuo
Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients.
January 2008, Blood purification,
Copied contents to your clipboard!